We are live on
!
Find out more
Hudson Bay Capital Management Portfolio holdings
AUM
$29B
1-Year Est. Return
30.2%
This Fund
S&P 500
This Quarter
Est. Return
+12.23%
1 Year Est. Return
+30.2%
3 Year Est. Return
+99.99%
5 Year Est. Return
+135.78%
10 Year Est. Return
+498.47%
AUM
$15.8B
AUM Growth
+$3.05B
(+24%)
Cap. Flow
+$637M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
35%
Holding
1,012
New
229
Increased
151
Reduced
185
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$353M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$286M |
| 3 |
Advanced Micro Devices
AMD
|
+$273M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$151M |
| 5 |
Amazon
AMZN
|
+$117M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$685M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$239M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$221M |
| 4 |
Apple
AAPL
|
+$205M |
| 5 |
Microsoft
MSFT
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Communication Services | 9.2% |
| 3 | Consumer Discretionary | 8.57% |
| 4 | Financials | 6.3% |
| 5 | Healthcare | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
PUT
Monro
MNRO
$355M
| $1.03M | 0.01% |
+35,000
| New | +$985K |
|
502
FIVE9
FIVN
$2.34B
| $1.02M | 0.01% |
+12,930
| New | +$900K |
|
|
MNTN
503
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
| $1.02M | 0.01% |
92,982
-7,018
| -7% | -$76.3K |
|
|
BZAI
504
Blaize Holdings
BZAI
$161M
| $1.02M | 0.01% |
94,807
-5,253
| -5% | -$55.9K |
|
505
Fortress Biotech
FBIO
$90.4M
| $985K | 0.01% |
+327,235
| New | +$865K |
|
506
Eos Energy Enterprises
EOSE
$1.55B
| $983K | 0.01% |
+901,710
| New | +$1.31M |
|
507
MP Materials
MP
$9.6B
| $979K | 0.01% |
49,310
| – | – |
|
|
DISH
508
DELISTED
DISH Network Corp.
DISH
| $928K | 0.01% |
160,831
| – | – |
|
509
IHS Holding
IHS
$2.81B
| $920K | 0.01% |
+200,000
| New | +$990K |
|
510
MoonLake Immunotherapeutics
MLTX
$1.46B
| $906K | 0.01% |
+15,000
| New | +$773K |
|
|
HA
511
DELISTED
Hawaiian Holdings, Inc.
HA
| $905K | 0.01% |
+63,707
| New | +$473K |
|
512
Olema Pharmaceuticals
OLMA
$933M
| $877K | 0.01% |
+62,500
| New | +$840K |
|
513
Scilex Holding
SCLX
$47.5M
| $866K | 0.01% |
12,134
-1,428
| -11% | -$74.1K |
|
514
Alkermes
ALKS
$8.46B
| $832K | 0.01% |
30,000
| – | – |
|
515
Aurinia Pharmaceuticals
AUPH
$2.07B
| $832K | 0.01% |
92,500
-63,984
| -41% | -$527K |
|
516
PTC Therapeutics
PTCT
$6.14B
| $827K | 0.01% |
30,000
| – | – |
|
517
Pliant Therapeutics
PLRX
$65.6M
| $815K | 0.01% |
+45,000
| New | +$684K |
|
518
Recursion Pharmaceuticals
RXRX
$1.76B
| $789K | 0.01% |
80,000
+40,000
| +100% | +$285K |
|
|
ETRN
519
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $786K | 0.01% |
77,228
-246,164
| -76% | -$2.32M |
|
520
BioCryst Pharmaceuticals
BCRX
$2.69B
| $779K | ﹤0.01% |
130,000
+65,000
| +100% | +$377K |
|
521
Viridian Therapeutics
VRDN
$2.63B
| $766K | ﹤0.01% |
+35,176
| New | +$555K |
|
522
NCR Atleos
NATL
$3.45B
| $759K | ﹤0.01% |
+31,261
| New | +$716K |
|
523
Prothena Corp
PRTA
$474M
| $727K | ﹤0.01% |
20,000
-12,500
| -38% | -$481K |
|
524
Tower Semiconductor
TSEM
$30.5B
| $693K | ﹤0.01% |
22,706
-146,574
| -87% | -$3.82M |
|
525
Tecnoglass Holdings Inc.
TGLS
$1.87B
| $689K | ﹤0.01% |
15,082
-106,231
| -88% | -$3.84M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Hudson Bay Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Hudson Bay Capital Management held 1,012 positions worth $15.8B, up 24% from $12.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Hudson Bay Capital Management deployed $637M of net new capital in Q4 2023, opening 229 new positions and adding to 151 existing holdings. Its largest new stake was Pioneer Natural Resource Co.: 642,236 shares worth $144M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 21% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI ACWI ETF, an estimated $239M trimmed.
- Hudson Bay Capital Management's largest Q4 2023 buy was Pioneer Natural Resource Co.: 642,236 shares worth $144M.
- Hudson Bay Capital Management added most to Berkshire Hathaway Class B in Q4 2023, an estimated $353M increase.
- Hudson Bay Capital Management's biggest Q4 2023 reduction was iShares MSCI ACWI ETF, cutting an estimated $239M.
- Hudson Bay Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $685M.
- Hudson Bay Capital Management's ten largest holdings make up 35% of its $15.8B portfolio in Q4 2023.
- Hudson Bay Capital Management opened 229 new positions and closed 309 in Q4 2023.
- Hudson Bay Capital Management's portfolio value rose 24% quarter-over-quarter to $15.8B.
Based on Hudson Bay Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.